Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Correlate CMV-Specific Cell Mediated Immunity With Risk of CMV Disease and With Clinical Response to Therapy Following Solid Organ Transplantation

NCT01558037 is registered in ClinicalTrials.gov with Michael Ison as lead sponsor.

NCT NCT01558037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01558037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Correlate CMV-Specific Cell Mediated Immunity With Risk of CMV Disease and With Clinical Response to Therapy Following Solid Organ Transplantation
Lead sponsor
Michael Ison
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
March 31, 2012
Enrollment
113 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

awaiting organ transplant, infection in solid organ transplant recipients